Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuma Matsui

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Internal Medicine (Tokyo, Japan)|June 21, 2021
Rheumatoid Arthritis Accompanying Diffuse PanbronchiolitisTaisuke Isono, Shun Shibata, Yuma Matsui, et al.
Respiratory Medicine Case Reports|May 15, 2023
Minoxidil-induced lung disease, masquerading as hypersensitivity pneumonitisDaisuke Takekosh, Teruhisa Nemoto, Susumu Saito, et al.
Thoracic Cancer|March 12, 2021
A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non-small cell lung cancerTaisuke Isono, Naho Kagiyama, Shun Shibata, et al.
Internal Medicine (Tokyo, Japan)|June 16, 2020
Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of DasatinibDaisuke Takekoshi, Yuma Matsui, Takuya Akutsu, et al.
Nature Communications|August 22, 2022
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task ForceQingbo S Wang, Ryuya Edahiro, Ho Namkoong, et al.
Nature|August 8, 2022
DOCK2 is involved in the host genetics and biology of severe COVID-19Ho Namkoong, Ryuya Edahiro, Tomomi Takano, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Internal Medicine (Tokyo, Japan)|June 21, 2021
Rheumatoid Arthritis Accompanying Diffuse PanbronchiolitisTaisuke Isono, Shun Shibata, Yuma Matsui, et al.
Respiratory Medicine Case Reports|May 15, 2023
Minoxidil-induced lung disease, masquerading as hypersensitivity pneumonitisDaisuke Takekosh, Teruhisa Nemoto, Susumu Saito, et al.
Thoracic Cancer|March 12, 2021
A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non-small cell lung cancerTaisuke Isono, Naho Kagiyama, Shun Shibata, et al.
Internal Medicine (Tokyo, Japan)|June 16, 2020
Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of DasatinibDaisuke Takekoshi, Yuma Matsui, Takuya Akutsu, et al.
Nature Communications|August 22, 2022
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task ForceQingbo S Wang, Ryuya Edahiro, Ho Namkoong, et al.
Nature|August 8, 2022
DOCK2 is involved in the host genetics and biology of severe COVID-19Ho Namkoong, Ryuya Edahiro, Tomomi Takano, et al.
Pageof 1